List of SBIR/STTR awards granted to Innovative BioTherapies, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Innovative BioTherapies, Inc. in August, 2020 for $563,353.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44TR001324-02A1 | Phase II | 563,353 | August 15, 2020 | |||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. in August, 2022 for $325,257.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL164239-01 | Phase I | 325,257 | August 15, 2022 | |||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. in August, 2015 for $323,816.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR001324-01 | Phase I | 323,816 | August 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. in August, 2015 for $655,205.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL118792-01A1 | Phase I | 655,205 | August 15, 2015 | |||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. in April, 2015 for $588,700.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL127830-01 | Phase I | 588,700 | April 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. for $137,388.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK082050-01 | Phase I | 137,388 | ||||||||
A SBIR Phase II contract was awarded to Innovative BioTherapies, Inc. for $1,155,440.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK074289-03 | Phase II | 1,155,440 | ||||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. for $499,870.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK080529-01 | Phase I | 499,870 | ||||||||
A SBIR Phase II contract was awarded to Innovative BioTherapies, Inc. for $1,432,240.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44TR000630-03A1 | Phase II | 1,432,240 | ||||||||
A SBIR Phase II contract was awarded to Innovative BioTherapies, Inc. for $1,990,130.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK082050-02 | Phase II | 1,990,130 | ||||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. for $364,723.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK097946-01 | Phase I | 364,723 | ||||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. for $249,999.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK075217-01A1 | Phase I | 249,999 | ||||||||
A SBIR Phase I contract was awarded to Innovative BioTherapies, Inc. for $500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK074289-01 | Phase I | 500,000 |
